Condensed Consolidated Balance Sheets - USD ($)	Jun. 30, 2020	Dec. 31, 2019
Current assets:
Cash and cash equivalents	$ 29,970,617	$ 564,124
Restricted cash	50,000
Deferred offering costs		121,712
Prepaid expenses and other current assets	2,828,556	78,057
Total current assets	32,849,173	763,893
Non-current assets:
Property and equipment, net	655,495	458,591
Right-of-use asset	384,081
Goodwill	29,367,213
Total assets	63,255,962	1,222,484
Current liabilities:
Accounts payable	915,206	715,653
Accrued expenses	1,575,068	2,634,790
Short-term debt	926,983
Right-of-use liability, current	29,287
Total current liabilities	3,446,544	3,350,443
Non-current liabilities:
Right-of-use liability, long-term	378,885
Total liabilities	3,825,429	3,350,443
Stockholders’ Equity (Deficit)
Preferred Stock, $0.001 par value, authorized 10,000,000 shares: Series 1 Convertible Preferred Stock, 3,880 and 0 shares authorized at June 30, 2020 and December 31, 2019, respectively, 3,879 and 0 shares issued and outstanding as of June 30, 2020 and December 31, 2019, respectively.	4
Common Stock, $0.001 par value, authorized 100,000,000 shares: Common Stock, 5,843,203 and 2,627,533 common shares issued and outstanding as of June 30, 2020 and December 31, 2019, respectively. Common Stock, 5,843,203 and 2,627,533 common shares issued and outstanding as of June 30, 2020 and December 31, 2019, respectively.	5,843	2,628
Additional Paid in Capital	89,406,633	10,651,073
Accumulated Deficit	(29,981,947)	(12,781,660)
Total Stockholders' Equity (Deficit)	59,430,533	(2,127,959)
Total Liabilities and Stockholders’ Equity (Deficit)	$ 63,255,962	$ 1,222,484